Legacy Education Inc Dossier - Source-backed chat

Legacy Education Inc

LGCYNYSE

SectorConsumer Discretionary

IndustryEducation Services

Beta (adjusted)1.11

Intrinsic Value $14.18median of 6 methods · middle span $11-$22based on filings through 31 Mar 2026

Market Price $9.60Price as of 1 Oct 2026

UndervaluedIntrinsic value is 48% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $123M

Enterprise Value $102M

Shares Outstanding 14.2M diluted

Moat Rating Wide

Next Earnings Date12 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Legacy Education Inc. (NYSE American: LGCY) is a high-growth, profitable provider of career-focused healthcare education. The company is capitalizing on the persistent shortage of healthcare professionals in the United States by offering fast-tracked, accredited programs. With strong organic enrollment growth, successful integration of acquisitions like Contra Costa Medical Career College, and a robust balance sheet featuring minimal debt, LGCY is well-positioned to deliver long-term shareholder value.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets3 analysts · as of 18 Aug 2026

Low · most bearish analyst$14.50

Mean target$14.80

High · most bullish analyst$15.40

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$4.0020%

Tightened federal regulations (such as 90/10 rule definitions or aggressive audits) restrict enrollment capacity. Tuition flex defaults rise, leading to bad debt write-downs, compressing net margins to 5% and depressing the valuation multiple to distressed levels.

Base CaseCentral scenario

$14.8050%

Matches the consensus mean

Steady compounding supported by secular healthcare labor shortages. LGCY achieves a 15% revenue CAGR from its current run-rate, driven by organic enrollment growth and smooth integration of existing campuses. Net margins remain stable around 10% as operational efficiencies offset expansion costs.

Bull CaseUpside scenario

$18.6030%

Accelerated multi-state expansion, successful launch of new high-demand programs (such as Surgical Technology and Sterile Processing), and accretive M&A drive a 25% revenue CAGR. Operating leverage expands net margins to over 12.5%, and favorable regulatory conditions support a premium valuation multiple.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong secular tailwinds driven by the national shortage of healthcare workers.
Impressive financial performance with Q3 2026 revenue up 15% YoY and nine-month revenue up 29.7% YoY.
Robust balance sheet with $21.7 million in cash and minimal debt of $600K as of March 31, 2026.
High student outcomes, including an 82% nursing exam pass rate and a 75% job placement rate.

Key Investment Risks

High regulatory exposure to U.S. Department of Education rules, including Title IV funding eligibility and the 90/10 rule.
Dependence on regional markets, primarily in California, making it vulnerable to local economic and competitive shifts.
Execution risks associated with integrating acquisitions and scaling new campus locations.

Thesis Invalidation Triggers

Loss of national accreditation or Title IV eligibility for any major campus.
A sustained decline in new student starts for consecutive quarters.
Significant margin compression due to rising operational and compliance costs.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.